ppeba70384.png
pp547ef271.png
BREAST IMAGING:
PROCEDURES:
SUB-SPECIALTIES:
pp012bb986.png
pp5f0faa89.png
ppa1545b92.png
ppf289f140.png
ppfbb2cfa9.png
pp1594dde1.png
ppe707c62e.png
ppb9f67cca.png
ppf1888d72.png
ppd9e6f0d7.png
ppcac8ea80.png
pp700b7238.png
Quality Care
Exceptional Service
ppb9ff52ab.png
ppa598845d.png
pp059d6648.png
pp1a5b56f9.png
pp6f6d6e95.png
ppfcc81b94.png
pp322d6bbe.png
ppaf56cf8d.png
ppa598845d.png
pp08b6a8de.png
ppe446835c.png
ppc2685487.png
pp7afc2b0f.png
ppa598845d.png
ppfcc81b94.png
pp602f3d1b.png
ppfcc81b94.png
pp1a5b56f9.png
pp383c00e6.png
ppe087dad7.png
ppf157b8a4.png
pp361d7e96.png
ppe4086c62.png
pp361d7e96.png
pp3df4401b.gif
ppd3c47b0c.png
accounting degree schools
votech vocational schools
©Diagnostic Radioligy, P.C. - 2008
Website by LAPDesigns
Omaha Imaging Office Phone #:  (402) 397-7100
Village Pointe Office Phone #:  (402)  502-7226
Billing Phone #:  (402) 361-5270
pp02bd16d2.png
pp02bd16d2.png
Omaha Imaging Location:  501 N. 87th Street, #100, Omaha, NE, 68114
Village Pointe Location:  302 N. 168th Circle, Suite 202, Omaha, NE  68118-4089
MasterPagePhotos-<wbr>2010-<wbr>Apr-<wbr>15.gif
TextAnimationrev.2010-<wbr>Apr-<wbr>15.gif
Once cancer is diagnosed, everyone needs the best, most accurate information available with a comprehensive imaging perspective. That is why Diagnostic Radiology, P.C. (DRPC) provides complete capabilities and unique expertise for oncology imaging. Our board-certified radiologists are subspecialty fellowship-trained in a specific focus, such as nuclear medicine, MRI, CT, and body imaging, which translates into advanced diagnostic skill and unsurpassed expertise. In addition, the DRPC team collaborates weekly with referring physicians (medical and surgical oncologists, radiation oncologists and pathologists) at Jennie Edmundson at the multidisciplinary tumor board to provide the most efficient, focused care possible.
PET – Positron emission tomography (PET) represents one of our most powerful oncology imaging tools; it helps our radiologists detect tumors at their earliest, most treatable stage. And earlier detection is the key to effective treatment and survivability. PET captures tumor cells “in action”, making it a valuable tool for the clinical evaluation of patients with various cancers, including head and neck cancer, esophageal cancer, lung cancer, breast cancer, ovarian cancer, endometrial cancer, and colorectal cancer. Since PET images biochemical activity, it can accurately predict whether a tumor is benign or malignant, thereby avoiding surgical biopsy when a PET scan is negative. PET is also used to determine the stage of cancer accurately and evaluate the effectiveness of cancer therapy and medication, potentially sparing patients from uncomfortable treatments that are proving ineffective.
PET-CT fusion™ –  By combining images obtained through PET and CT —  a function
pp1f8b85ba.jpg
made possible by sophisticated image fusion software — oncologists are entering a new era. PET-CT fusion combines cellular imaging and structural imaging, providing the highest sensitivity, specificity, and accuracy available in cancer imaging today. For the physician, the fused image can provide more data in less time, leading to faster, more accurate diagnosis, treatment planning, and treatment monitoring.
Fusion assists the physician in determining the presence and size of a tumor, where it is located, and if it is spreading and allows physicians to be more selective in whom they take to the operating room. The modality aids in finding recurrences of cancer and can be used to guide the surgeon to the exact location of the malignancy and help the radiation oncologist localize treatment while avoiding injury to healthy tissue. For the patient, PET-CT fusion means a reduction in exam time and a potential reduction in invasive procedures such as biopsies and unnecessary surgeries.

Oncologic Imaging